Regulation of IκB kinase ε expression by the androgen receptor and the nuclear factor-κB transcription factor in prostate cancer

Molecular Cancer Research

Volumn 5, Issue 1, 2007, Pages 87-94

  Péant, Benjamin ^a   Diallo, Jean Simon ^a   Lessard, Laurent ^a   Delvoye, Nathalie ^a   Le Page, Cécile ^a   Saad, Fred ^a   Mes Masson, Anne Marie ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METRIBOLONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; AR PROTEIN, HUMAN; I KAPPA B KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CARTILAGE CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REGULATION; GENE EXPRESSION; GENE TRANSLOCATION; HORMONAL THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; CELL CULTURE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PROMOTER REGION; PROSTATE TUMOR; PROTEIN TRANSPORT; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL NUCLEUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B KINASE; MALE; METRIBOLONE; NEOPLASMS, HORMONE-DEPENDENT; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33846970226     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-06-0144     Document Type: Article

References (43)

1. Morris MJ, Scher HI. Novel strategies and therapeutics for the treatment of prostate carcinoma. Cancer 2000;89:1329-48.
2. Crawford ED, Eisenberger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989;321:419-24.
3. Culine S, Droz JP. Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: a decade of progress? Ann Oncol 2000;11:1523-30.
4. Savarese DM, Halabi S, Hars V, et al. Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B. J Clin Oncol 2001;19:2509-16.
5. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 1999;18:6910-24.
6. Baldwin AS, Jr. Series introduction: the transcription factor NF-κB and human disease. J Clin Invest 2001;107:3-6.
7. Suh J, Rabson AB. NF-κB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem 2004;91:100-17.
8. Chen CD, Sawyers CL. NF-κB activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol 2002;22:2862-70.
9. Gasparian AV, Yao YJ, Kowalczyk D, et al. The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells. J Cell Sci 2002;115:141-51.
10. Ayala GE, Dai H, Ittmann M, et al. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 2004;64:6082-90.
11. Ross JS, Kallakury BV, Sheehan CE, et al. Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas: correlation of nuclear factor-κB immunoreactivity with disease recurrence. Clin Cancer Res 2004;10:2466-72.
12. Shukla S, MacLennan GT, Fu P, et al. Nuclear factor-KB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 2004;6:390-400.
13. Sweeney C, Li L, Shanmugam R, et al. Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin Cancer Res 2004;10:5501-7.
14. Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F. Nuclear factor-κB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 2004;10:8460-4.
15. Lessard L, Mes-Masson AM, Lamarre L, Wall L, Lattouf JB, Saad F. NF-κB nuclear localization and its prognostic significance in prostate cancer. BJU Int 2003;91:417-20.
16. Le Page C, Koumakpayi IH, Lessard L, Mes-Masson AM, Saad F. EGFR and Her-2 regulate the constitutive activation of NF-κB in PC-3 prostate cancer cells. Prostate 2005;65:130-40.
17. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-95.
18. Ismail HA, Lessard L, Mes-Masson AM, Saad F. Expression of NF-κB in prostate cancer lymph node metastases. Prostate 2004;58:308-13.
19. Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F. Nuclear localisation of nuclear factor-κB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer 2005;93:1019-23.
20. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002;109 Suppl:S81-96.
21. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004;18:2195-224.
22. Israel A. The IKK complex: an integrator of all signals that activate NF-κB? Trends Cell Biol 2000;10:129-33.
23. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 2000;18:621-63.
24. Gilmore TD. The Rel/NF-κB signal transduction pathway: introduction. Oncogene 1999;18:6842-4.
25. Chariot A, Leonardi A, Muller J, Bonif M, Brown K, Siebenlist U. Association of the adaptor TANK with the IκB kinase (IKK) regulator NEMO connects IKK complexes with IKKe and TBK1 kinases. J Biol Chem 2002;277:37029-36.
26. Peters RT, Liao SM, Maniatis T. IKKε is part of a novel PMA-inducible IκB kinase complex. Mol Cell 2000;5:513-22.
27. Pomerantz JL, Baltimore D. NF-κB activation by a signaling complex containing TRAF2, TANK, and TBK1, a novel IKK-related kinase. EMBO J 1999;18:6694-704.
28. Bonnard M, Mirtsos C, Suzuki S, et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription. EMBO J 2000;19:4976-85.
29. Aupperle KR, Yamanishi Y, Bennett BL, Mercurio F, Boyle DL, Firestein GS. Expression and regulation of inducible IκB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell Immunol 2001;214:54-9.
30. Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003;4:491-6.
31. Wang N, Ahmed S, Haqqi TM. Genomic structure and functional characterization of the promoter region of human IκB kinase-related kinase IKKi/IKKε gene. Gene 2005;353:118-33.
32. Shimada T, Kawai T, Takeda K, et al. IKK-i, a novel lipopolysaccharide- inducible kinase that is related to IκB kinases. Int Immunol 1999;11:1357-62.
33. Kravchenko VV, Mathison JC, Schwamborn K, Mercurio F, Ulevitch RJ. IKKi/IKKε plays a key role in integrating signals induced by pro-inflammatory stimuli. J Biol Chem 2003;278:26612-9.
34. Altuwaijri S, Lin HK, Chuang KH, et al. Interruption of nuclear factor κB signaling by the androgen receptor facilitates 12-O- tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Cancer Res 2003;63:7106-12.
35. Keller ET, Chang C, Ershler WB. Inhibition of NFκB activity through maintenance of IκBα levels contributes to dihydrotestosterone- mediated repression of the interleukin-6 promoter. J Biol Chem 1996;271:26267-75.
36. Adli M, Baldwin AS. IKK-i/IKKε controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem 2006;281:26976-84.
37. Nomura F, Kawai T, Nakanishi K, Akira S. NF-κ activation through IKKi-dependent I-TRAF/TANK phosphorylation. Genes Cells 2000;5:191-202.
38. Pomerantz JL, Baltimore D. Two pathways to NF-κB. Mol Cell 2002;10:693-5.
39. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003;300:1148-51.
40. McKay LI, Cidlowski JA. CBP (CREB binding protein) integrates NF-κB (nuclear factor-κB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 2000;14:1222-34.
41. Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Janne OA. Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 1996;271:24151-6.
42. Pfaftl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
43. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86.